5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo
Clinton M. Hasenour, D. Emerson Ridley, Curtis C. Hughey, Freyja D. James, E. Patrick Donahue, Jane Shearer, Benoit Viollet, Marc Foretz, David H. Wasserman
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of '5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo'. Together they form a unique fingerprint.